Literature DB >> 19031960

Association between genetic polymorphisms and ovarian cancer risk.

Laetitia Delort1, Nasséra Chalabi, Samir Satih, Nadège Rabiau, Fabrice Kwiatkowski, Yves-Jean Bignon, Dominique J Bernard-Gallon.   

Abstract

BACKGROUND: The etiology of ovarian cancer is not fully understood. Polymorphisms in low penetrance genes involved in carcinogen and estrogen metabolism are hypothesized to play a role in the initiation of carcinogenesis. PATIENTS AND METHODS: A case-control study was conducted to investigate the role of these polymorphisms in ovarian cancer risk. The participants were genotyped for eleven polymorphisms in seven genes involved in estrogen and xenobiotic metabolism (CYP1A1, CYP1B1, COMT, GSTP1, NAT2, estrogen receptor ESR, and progesterone receptor PGR). RESULTS AND
CONCLUSION: The odds ratios for ovarian cancer risk were 2.02 (95% confidence interval [CI] = 1.14-3.56) in the NAT2 intermediate acetylators and 4.07 (95% CI = 1.30-12.70) in the slow acetylators. At least three cumulative high-risk genotypes increased ovarian cancer risk, but not significantly. More studies are needed in order to define genetic ovarian risk factors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19031960

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

1.  Unbalanced estrogen metabolism in ovarian cancer.

Authors:  Muhammad Zahid; Cheryl L Beseler; James B Hall; Tricia LeVan; Ercole L Cavalieri; Eleanor G Rogan
Journal:  Int J Cancer       Date:  2014-01-25       Impact factor: 7.396

2.  Evaluation of COMT Gene rs4680 Polymorphism as a Risk Factor for Endometrial Cancer.

Authors:  Pradeep Kumar; Garima Singh; Vandana Rai
Journal:  Indian J Clin Biochem       Date:  2018-12-04

3.  Association between the CYP1B1 polymorphisms and risk of cancer: a meta-analysis.

Authors:  Jie-Ying Liu; Yu Yang; Zhi-Zhong Liu; Jian-Jun Xie; Ya-Ping Du; Wei Wang
Journal:  Mol Genet Genomics       Date:  2014-12-05       Impact factor: 3.291

4.  Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and ovarian cancer risk: a meta-analysis.

Authors:  Theodoros N Sergentanis; Konstantinos P Economopoulos; Souzana Choussein; Nikos F Vlahos
Journal:  Mol Biol Rep       Date:  2012-06-26       Impact factor: 2.316

5.  The ovarian carcinoma risk with the polymorphisms of CYP1B1 come from the positive selection.

Authors:  Liying Zhang; Liyuan Feng; Meng Lou; Xihan Deng; Chuanzhong Liu; Li Li
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

6.  Progesterone receptor PROGINS and +331G/A polymorphisms confer susceptibility to ovarian cancer: a meta-analysis based on 17 studies.

Authors:  Ting Liu; Lilan Chen; Xiangjun Sun; You Wang; Shu Li; Xia Yin; Xinran Wang; Chenhuan Ding; He Li; Wen Di
Journal:  Tumour Biol       Date:  2013-11-07

Review 7.  CYP1A1 and GSTP1 gene variations in breast cancer: a systematic review and case-control study.

Authors:  Sumaira Akhtar; Ishrat Mahjabeen; Zertashia Akram; Mahmood Akhtar Kayani
Journal:  Fam Cancer       Date:  2016-04       Impact factor: 2.375

8.  Association between the COMT Val158Met polymorphism and risk of cancer: evidence from 99 case-control studies.

Authors:  Quan Zhou; Yan Wang; Aihua Chen; Yaling Tao; Huamei Song; Wei Li; Jing Tao; Manzhen Zuo
Journal:  Onco Targets Ther       Date:  2015-10-05       Impact factor: 4.147

Review 9.  Associations of the glutathione S-transferase P1 Ile105Val genetic polymorphism with gynecological cancer susceptibility: a meta-analysis.

Authors:  Erjiang Zhao; Kai Hu; Yan Zhao
Journal:  Oncotarget       Date:  2017-06-20

10.  MassArray analysis of genomic susceptibility variants in ovarian cancer.

Authors:  Sonali Verma; Indu Sharma; Varun Sharma; Amrita Bhat; Ruchi Shah; Gh Rasool Bhat; Bhanu Sharma; Divya Bakshi; Ashna Nagpal; Ajay Wakhloo; Audesh Bhat; Rakesh Kumar
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.